Skip to main content

News

You are here

UM Ventures News

UM Ventures News
Partner News

University System of Maryland Names Mike Ravenscroft Managing Director of the Maryland Momentum Fund

Thursday, September 8, 2022

Technical.ly Baltimore: UMB, in partnership with alumni, wants to commercialize rare disease treatments

Wednesday, August 3, 2022

GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline

Tuesday, July 26, 2022

Published Study Results Demonstrate Substantial Length of Stay and Hospital Cost Reductions with Use of CoapTech's PUMA-G System™ for Gastrostomy When Compared to Usual Care Methods

Wednesday, May 11, 2022

Technical.ly Baltimore: From nanosensors to vaccines, these creations won UMD’s Invention of the Year awards

Thursday, May 5, 2022

BioBuzz: Baltimore Medtech Sector a Key Asset for Ascending Biotech Cluster

Wednesday, April 20, 2022

Xcision Announces Start of Breast Cancer Treatments Using GammaPod™ Stereotactic Radiotherapy System at Leading Italian Hospital

Thursday, April 14, 2022

Technical.ly Baltimore: CoapTech prepares clinical trials for its ultrasound-based device

Friday, March 11, 2022

Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic space

Tuesday, March 8, 2022

CoapTech Announces IDE Approval from FDA to Initiate Clinical Trial for its PUMA-G Peds System for Pediatric Gastrostomy

Tuesday, March 8, 2022

Pages